RE:RE:Strategic investor among best-case scenariosMacman everyday you show your immaturity. Your to weak to hold this stock. What are you losing your shirt? I can only hope you are.
Risk from trials
The work for all the approved drugs took years of research and several trial stages, each with a high level of risk for the respective company. All of this is to say investors should be ready to play the long game when it comes to pharmaceutical investing. Dips in share price are common if a company misses a target deadline or a drug doesn’t perform exactly as it was promised during a trial.